Bayer Group Condensed Consolidated Statements of Cash Flows

€ million

 

Q3 2025

 

Q3 2026

 

9M 2025

 

9M 2026

Income after income taxes

 

(959)

 

(661)

 

155

 

2,335

Income taxes

 

(202)

 

(127)

 

88

 

187

Financial result

 

618

 

678

 

1,551

 

1,723

Income taxes paid

 

(178)

 

(356)

 

(792)

 

(946)

Depreciation, amortization and impairment losses (loss reversals)

 

1,005

 

1,553

 

2,451

 

3,965

Change in pension provisions

 

(137)

 

(140)

 

(422)

 

(443)

(Gains) losses on retirements of noncurrent assets

 

(33)

 

(136)

 

(278)

 

(311)

Decrease (increase) in inventories

 

(116)

 

(302)

 

551

 

178

Decrease (increase) in trade accounts receivable

 

2,877

 

2,465

 

(1,711)

 

(950)

(Decrease) increase in trade accounts payable

 

342

 

244

 

(649)

 

(356)

Changes in other working capital, other noncash items

 

(1,532)

 

(2,587)

 

784

 

(5,855)

Net cash provided by (used in) operating activities

 

1,685

 

631

 

1,728

 

(473)

Cash outflows for additions to property, plant, equipment and intangible assets

 

(836)

 

(720)

 

(1,689)

 

(1,791)

Cash inflows from the sale of property, plant, equipment and other assets

 

62

 

127

 

165

 

346

Cash inflows from (outflows for) divestments less divested cash

 

–

 

–

 

(1)

 

–

Cash inflows from noncurrent financial assets

 

119

 

9

 

135

 

19

Cash outflows for noncurrent financial assets

 

(44)

 

(64)

 

(155)

 

(127)

Cash outflows for (inflows from) acquisitions less acquired cash

 

(1)

 

–

 

(198)

 

(300)

Interest and dividends received

 

105

 

114

 

258

 

269

Cash inflows from (outflows for) current financial assets

 

(472)

 

(2,547)

 

733

 

(1,924)

Net cash provided by (used in) investing activities

 

(1,067)

 

(3,081)

 

(752)

 

(3,508)

Capital contributions from noncontrolling interests

 

–

 

3,000

 

–

 

3,000

Payments for transaction costs in connection with capital measures

 

–

 

(68)

 

–

 

(68)

Dividend payments

 

(8)

 

(7)

 

(116)

 

(119)

Issuances of debt

 

3,440

 

7,154

 

5,935

 

10,341

Retirements of debt

 

(2,344)

 

(2,345)

 

(5,708)

 

(5,698)

Interest paid including interest-rate swaps

 

(358)

 

(351)

 

(1,104)

 

(1,022)

Interest received from interest-rate swaps

 

–

 

33

 

–

 

33

Net cash provided by (used in) financing activities

 

730

 

7,416

 

(993)

 

6,467

Change in cash and cash equivalents due to business activities

 

1,348

 

4,966

 

(17)

 

2,486

Cash and cash equivalents at beginning of period

 

4,557

 

4,289

 

6,191

 

6,671

Change in cash and cash equivalents due to exchange rate movements

 

(3)

 

4

 

(272)

 

108

Effects from hyperinflation of cash flows

 

(5)

 

(3)

 

(5)

 

(9)

Cash and cash equivalents at end of period

 

5,897

 

9,256

 

5,897

 

9,256